While originally approved for type 2 diabetes and cardiovascular disease, these drugs have demonstrated significant efficacy for weight loss, fueling public demand and legislative proposals to expand coverage
For example, semaglutide can reduce N-terminal pro brain natriuretic peptide (NT proBNP) by 30% in heart failure patients with preserved ejection fraction (HFpEF), and reduce the risk of cardiovascular death and hospitalization due to heart failure by 31%
Semaglutide is already used in other forms, including injectable Wegovy and diabetes medications such as Ozempic and Rybelsus, but the breakthrough here is the ability to take it as a oncedaily tablet - with no needles involved
Theyll also keep an eye on your progress, adjust your dose as needed, and help you manage any side effects along the way
It treats type 2 diabetes